Your browser doesn't support javascript.
loading
In healthy volunteers, taking flucloxacillin with food does not compromise effective plasma concentrations in most circumstances.
Gardiner, Sharon J; Drennan, Philip G; Begg, Ronald; Zhang, Mei; Green, Jared K; Isenman, Heather L; Everts, Richard J; Chambers, Stephen T; Begg, Evan J.
Afiliação
  • Gardiner SJ; Department of Infectious Diseases, Christchurch Hospital, Christchurch, New Zealand.
  • Drennan PG; Department of Clinical Pharmacology, Christchurch Hospital, Christchurch, New Zealand.
  • Begg R; Pharmacy Services, Christchurch Hospital, Christchurch, New Zealand.
  • Zhang M; Department of Infectious Diseases, Christchurch Hospital, Christchurch, New Zealand.
  • Green JK; Department of Clinical Pharmacology, Christchurch Hospital, Christchurch, New Zealand.
  • Isenman HL; Department of Medicine, University of Otago-Christchurch, Christchurch, New Zealand.
  • Everts RJ; Department of Medicine, University of Otago-Christchurch, Christchurch, New Zealand.
  • Chambers ST; Toxicology, Canterbury Health Laboratories, Christchurch, New Zealand.
  • Begg EJ; Department of Infectious Diseases, Christchurch Hospital, Christchurch, New Zealand.
PLoS One ; 13(7): e0199370, 2018.
Article em En | MEDLINE | ID: mdl-30001392
ABSTRACT
It is usually recommended that flucloxacillin is given on an empty stomach. The aim of this study was to compare total and free flucloxacillin concentrations after oral flucloxacillin, given with and without food, based on contemporary pharmacokinetic and pharmacodynamic targets. Flucloxacillin 1000 mg orally was given to 12 volunteers, after a standardised breakfast and while fasting, on two separate occasions. Flucloxacillin concentrations over 12 hours were measured by liquid chromatography-tandem mass spectrometry. Pharmacokinetic parameters, and pharmacodynamic endpoints related to target concentration achievement, were compared in the fed and fasting states. For free flucloxacillin, the fed/fasting area under the concentration-time curve from zero to infinity (AUC0-∞) ratio was 0.80 (p<0.01, 90% CI 0.70-0.92), the peak concentraton (Cmax) ratio 0.51 (p<0.001, 0.42-0.62) and the time to peak concentration (Tmax) ratio 2.2 (p<0.001, 1.87-2.55). The ratios for total flucloxacillin concentrations were similar. The mean (90% CI) fed/fasting ratios of free concentrations exceeded for 30%, 50% and 70% of the first 6 hours post-dose were 0.74 (0.63-0.87, fed inferior p<0.01), 0.95 (0.81-1.11, bioequivalent) and 1.15 (0.97-1.36, fed non-inferior), respectively. Results for 8 hours post-dose and those predicted for steady state were similar. Comparison of probability of target attainments for fed versus fasting across a range of minimum inhibitory concentrations (MICs) were in line with these results. Overall, this study shows that food reduced the AUC0-∞ and Cmax, and prolonged the Tmax of both free and total flucloxacillin concentrations compared with the fasting state, but achievement of free concentration targets associated with efficacy was in most circumstances equivalent. These results suggest that taking flucloxacillin with food is unlikely to compromise efficacy in most circumstances.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Voluntários Saudáveis / Floxacilina / Antibacterianos Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Voluntários Saudáveis / Floxacilina / Antibacterianos Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article